Haemonetics (HAE) Reports Q3 Fiscal Earnings Surpassing Expectations: $1.31 EPS, Revenue $339M

Haemonetics Corp. (HAE) released fiscal third-quarter results on February 5, 2026, reporting earnings of $44.7 million or 95 cents per share, with adjusted net income of $1.31 per share. Revenue reached $339 million, exceeding the $334.2 million average forecast from six Zacks analysts. The results surpassed analyst expectations, with the average estimate for adjusted earnings at $1.27 per share. Management guidance for the full year is $4.90 to $5.00 per share.